Johnson & Johnson says medtech brands now called ‘Johnson & Johnson MedTech’

Johnson & Johnson shared that its medical technology businesses – Ethicon, DePuy Synthes, Biosense Webster, Abiomed and CERENOVUS – will now go by the name Johnson & Johnson MedTech. “This is the next step of Johnson & Johnson’s updated brand and visual identity announced in September 2023. This move underscores Johnson & Johnson’s leadership in medical technology with a focus on cardiovascular, orthopaedic, surgery and vision solutions. Today’s announcement has no impact on the medical technology products and solutions currently offer to customers… Partners, customers and consumers will begin to see the change come to life on social media channels and marketing materials over the coming weeks. The updated brand and visual identity will have no impact on the Johnson & Johnson MedTech portfolio,” the company stated.